Navigation Links
Almost Family Announces Record Quarterly and Year End Results
Date:3/10/2008

discontinued operations, was $7,603,560 or $1.36 per diluted share in the year ended December 31, 2007 and $4,239,443 or $.80 per diluted share in 2006.

VN Revenue Comparison for the Year

Due to the significant impact of acquisition activities on VN revenue growth, the following tables are presented comparing revenue growth by market type for the years ended December 31, 2007 and 2006:

VN Revenue Comparison

by Market Type - All # of

VN Operations Mkts 2007 2006 Change Percent

Newly acquired markets 16 $24,933,372 $1,230,132 $23,703,240

Markets with in-market

acquisitions 10 17,944,250 11,830,306 6,113,944 51.7%

Acquisition related

markets 26 42,877,622 13,060,439 29,817,183

Markets with no

acquisition impact 25 53,342,327 42,129,819 11,212,508 26.6%

51 $96,219,949 $55,190,258 $41,029,691 74.3%

VN revenues grew approximately $41 million between years of which 58% came from newly acquired markets, 15% came in markets with in-market acquisitions and 27% came from markets with no acquisition impact.

Results of operations for the years ended December 31, 2007 and 2006 are set forth in the tables below:

December December

2007 2006

Amount % Rev Amount % Rev

Net revenues

Visiting Nurses $96,219,949 72.8% $55,190,258 60.9%

Personal Care 35,910,107 27.2% 35,455,236 39.1%

$132,130,056 100.0% $90,645,494 100.0%

Operating income

Visiting Nurses $19,592,144 20.4% $9,098,996 16.5%

Personal Care 3,412,008 9.5% 3,899,545 11.
'/>"/>

SOURCE Almost Family, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. Hondros College Expands School of Nursing to Columbus and Dayton; Students Can Begin LPN Education Almost Immediately
2. UKs largest charity announces increase in funding to almost £4 billion over 5 years
3. Using the safety belt in the rear seats of the car reduces death risk by almost a half
4. Almost Half of 10-Year-Olds Have Tasted Alcohol
5. Almost Half of Doctors Have Prescribed Placebos
6. Cancer Killed Almost 8 Million Worldwide in 2007
7. Almost Family Announces Expansion of Revolving Credit Facility
8. Almost 1 in 5 Americans Going Without Health Care
9. Almost 2 Million U.S. Vets Lack Health Insurance
10. Doctors Applaud SCHIP Veto: Bill Supports Special Interests, Not Kids; Almost Half of Funds Go to Doctors & Seniors
11. Almost 90 percent of children reported experiencing sexual violence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...HARRISBURG, Pa., Nov. 21 /PRNewswire-USNewswire/ -...a, Governor Edward G. Rendell today remembered Li...ong teacher, an important partner in public servic...ylvania. , , "As the first woman elected li...ed public servant," said Governor Rendell. "Her fa...
(Date:11/21/2008)...But researchers remain cautious about future antib..., FRIDAY, Nov. 21 (HealthDay News) -- People with...disease (COPD) may be able to reduce the frequency... common antibiotic, a new report says. , The s... the American Journal of Respiratory and Critical...
(Date:11/21/2008)...MORGANTOWN, W.Va., Nov. 21 /PRNewswire-USNewswire/...examining whether a smokeless, spitless tobacco pr...e researchers have found that RJ Reynolds, Camel S...fy addiction - contains surprisingly high levels o...icotine than most other snuff products," said Bruc...
(Date:11/21/2008)...NEW YORK, Nov. 21 The general memb...ted to induct three new individuals at their Annua...he Pierre hotel in New York. A,Lifetime Achieveme...uctees into the Medical Advertising Hall of Fame a...g career with an account position,at Sudler &...
Breaking Medicine News(10 mins):Health News:Pennsylvania Governor Rendell Remembers, Celebrates the Life of Lt. Governor Catherine Baker Knoll During Capitol Tribute 2Health News:Pennsylvania Governor Rendell Remembers, Celebrates the Life of Lt. Governor Catherine Baker Knoll During Capitol Tribute 3Health News:Long-Term Erythromycin Cut COPD Complications 2Health News:Experts Say New Tobacco Product Targets Young Adults 2Health News:Experts Say New Tobacco Product Targets Young Adults 3Health News:Ronald Pantello, Harry Sweeney, and David Wood Voted Into Medical Advertising Hall of Fame. 2Health News:Ronald Pantello, Harry Sweeney, and David Wood Voted Into Medical Advertising Hall of Fame. 3
...rayers can help heart patients in the recovery pro...s at Duke // University Medical Centre. Researcher...apy showed a reduction death, heart failure, post-...an those without such therapies. 150 patients fro...
...ichard Greenberg and colleagues compared their Cel...cell culture with calf lymph derived vaccine. Smal... vaccine virus derived from calf lymph. This vacci...develop serious or life threatening adverse reacti...
...trontium ranelate for the treatment of osteoporosi... need careful interpretation. Nowadays the main tr...event bone breakdown. For patients with previous f...gent that enhances bone formation is preferable, a...
... recent research paper on chronic obstructive pulm...itation programs are often useful for patients of ...activities. Chronic obstructive pulmonary disease ...tricted airflow and conditions like lung tissue de...
Other Medicine News:Health News:The Benefits of Strontium in the treatment for Osteoporosis Questioned 2
(Date:11/21/2008)... -- Ikaria Holdings, Inc. today announced that it ...New Jersey Technology Council (NJTC), a 1,200-memb...support, networking opportunities, information and...rs. Ikaria earned the award based on criteria incl... provision. , , "We are delighted that the ...
(Date:11/20/2008)...ire/ -- New Jersey American Water has lifted the ...rs in the following municipalities in Middlesex, S...ounty , , , Dunellen , Ediso...South Plainfield , , , , Somerset C...idgewater , Green Brook , Hillsborou...
(Date:11/20/2008)...20 Arpida (SWX:,ARPN) a...ory Committee of the,U.S. Food and Drug Administr...l of intravenous iclaprim, an antibiotic currently...h complicated skin and skin structure infections,...sistant Staphylococcus,aureus (MRSA). , Ar...
(Date:11/20/2008)...re-FirstCall/ -- Duska Therapeutics,Inc., (OTC B...submitted its,pivotal Phase 3 ATPace clinical tri...ssessment (SPA) procedure with the U.S. Food and D...uring an agreement with the FDA, Duska intends to ...cebo-controlled and randomized Phase 3,clinical t...
Breaking Medicine Technology:Ikaria(R) Named Private Company of the Year by New Jersey Technology Council 2New Jersey American Water Lifts Precautionary Boil Water Advisory For Middlesex, Somerset and Union Counties 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 3Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 4Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 2Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 3Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 4Mindray to Attend 2007 RSNA Conference in Chicago 6781 1Mindray to Attend 2007 RSNA Conference in Chicago 6781 2Mindray to Attend 2007 RSNA Conference in Chicago 6781 3Genomic Health to Present at 19th Annual Piper Jaffray Health Care Conference 6779 1Genomic Health to Present at 19th Annual Piper Jaffray Health Care Conference 6779 2Eclipsys to Present at the Merrill Lynch Health Services Investor Conference 6777 1Eclipsys to Present at the Merrill Lynch Health Services Investor Conference 6777 2Eclipsys to Present at the Merrill Lynch Health Services Investor Conference 6777 3Danaher Closes Subsequent Offering Period for Tektronix 3B Acquires Over 90 25 of TEK Shares 6775 1Danaher Closes Subsequent Offering Period for Tektronix 3B Acquires Over 90 25 of TEK Shares 6775 2
...s TNF-alpha Production Through Inhibition,of PDE-4...ire/ -- Anacor,Pharmaceuticals, a privately held p... from its placebo-controlled Phase 1 trial of,AN27...gation for,the treatment of psoriasis. The trial s...omparable to existing topical,treatments for psori...
...k, June 06, 2007 /PRNewswire-FirstCall/,-- XTL Bio...ompleted the analysis of results from a Phase I cl...c Hepatitis C. This Phase I,trial was a placebo co... evaluated the safety, tolerability and antiviral ... The study enrolled 56,patients into seven cohorts...
Other Medicine Technology:Anacor Clinical Study of AN2728, a Novel Anti-Inflammatory,Compound, Shows Efficacy in Psoriasis 2XTL Provides Update on Phase I Clinical Trial of XTL-2125 2XTL Provides Update on Phase I Clinical Trial of XTL-2125 3
Inquire
...are is easy to configure for gravimetric calibrati...ndard method or enter your own parameters (number ... QualiTrace automatically manages the calibration ...from the balance to the software, which establishe...
Reservoir, Low Profile, Single Well, Flat Bottom, 90mL Available Sterile
Reagent Basin, 60mL, 5/Box
Medicine Products: